Reliability of Clinical Aspect and Transaminases Level as a Guidance for Screening for Sero-positive Hepatitis C in Multi-transfused β-Thalassaemia Patients

Reliability of Clinical Aspect and Transaminases Level as a Guidance for Screening for Sero-positive Hepatitis C in Multi-transfused β-Thalassaemia Patients

Mostrar outras versões (1)

Background: Although regular blood transfusion enhances the overall survival of thalassaemia patients, it have a significant threat of infection with transfusion-related infections, including hepatitis C; therefore, screening is mandatory. Routine screening with anti-hepatitis C Ab was recommended ...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Abdulrazzaq Mustafa Abbas, Najdat Shukur Mahmood, Dawood Salman Al-Azzawi
Formato:	Artigo
Idioma:	English
Publicado em:	College of medicine/ University of Diyala 2019-05-01
coleção:	Diyala Journal of Medicine
Assuntos:	β-thalassaemia, hepatitis C virus, serology, screening test
Acesso em linha:	https://www.djm.uodiyala.edu.iq/index.php/djm/article/view/236

Registros relacionados

Reliability of Clinical Aspect and Transaminases Level as a Guidance for Screening for Sero-positive Hepatitis C in Multi-transfused β-Thalassaemia Patients
por: Abdulrazzaq Mustafa Abbas, et al.
Publicado em: (2019-05-01)

The prevalence of hepatitis – B and C serological markers among patients with thalassaemia in Mosul
por: Bashar Sh. Mustafa
Publicado em: (2010-12-01)

The worldwide molecular spectrum and distribution of thalassaemia: a systematic review
por: Mina Ebrahimi, et al.
Publicado em: (2021-05-01)

Acquired alpha thalassaemia in myelodysplastic syndrome
por: Cheong, P
Publicado em: (2018)

THALASSAEMIA INTERMEDIA : AN UPDATE
por: Maria Domenica Cappellini, et al.
Publicado em: (2009-06-01)

THALASSAEMIA INTERMEDIA : AN UPDATE
por: Ali Taher, et al.
Publicado em: (2009-08-01)

Alloimmunization in Transfusion Dependent Thalassaemic Patients.
por: Saad H. Ahmed, et al.
Publicado em: (2010-04-01)

The “Thal-index” with the BTT prediction.exe to discriminate Beta thalassaemia traits from other microcytic anaemias.
por: Nilanga Nishad
Publicado em: (2014-08-01)

Iron Deficiency Anaemia and Beta Thalassaemia Trait in Anaemic Pregnant Women.
por: Haider H. AL – Shammari
Publicado em: (2010-10-01)

A study on transfusion-transmitted infections and other complications amongst children with beta-thalassaemia major attending a tertiary care institution in Kolkata
por: Archi Chandra, et al.
Publicado em: (2023-01-01)

Haematopoietic stem cell transplantation in thalassaemia major: A narrative review
por: Rabeya Yousuf, et al.
Publicado em: (2023-01-01)

Real‐world complication burden and disease management paradigms in transfusion‐related β‐thalassaemia in Greece: Results from ULYSSES, an epidemiological, multicentre, retrospective cross‐sectional study
por: Antonis Kattamis, et al.
Publicado em: (2023-08-01)

Effects of combined deferiprone with deferoxamine on right ventricular function in thalassaemia major
por: Alpendurada Francisco, et al.
Publicado em: (2012-01-01)

Consanguineous unions and endogamy in families of beta-thalassaemia patients from two Mediterranean populations: Tunisia and Italy
por: Ramla Weslati, et al.
Publicado em: (2019-11-01)

HBB Gene Mutations and Their Pathological Impacts on HbE/β-Thalassaemia in Kuala Terengganu, Malaysia
por: Hanan Kamel M. Saad, et al.
Publicado em: (2023-03-01)

Morbidity and mortality patterns in patients with thalassaemia during the COVID-19 pandemic in Sri Lanka; A single centre experience
por: R. Nisansala, et al.
Publicado em: (2022-01-01)

Seroepidemiology of hepatitis B virus (HBV) and relationship to serum transaminase levels in Indian population
por: Manoj Kumar, et al.
Publicado em: (2024-06-01)

Addressing Thalassaemia Management from Patients’ Perspectives: An International Collaborative Assessment
por: Eleftheria C. Economidou, et al.
Publicado em: (2024-04-01)

The Outcomes of Patients with Haemoglobin Disorders in Cyprus: A Joined Report of the Thalassaemia International Federation and the Nicosia and Paphos Thalassaemia Centres (State Health Services Organisation)
por: Michael Angastiniotis, et al.
Publicado em: (2022-11-01)

Prevalence of thalassaemia among childbearing-age Li and Han populations in Hainan Province
por: Fangchao Tao, et al.
Publicado em: (2024-12-01)

Gene Mutation Spectrum among Alpha-Thalassaemia Patients in Northeast Peninsular Malaysia
por: Divashini Vijian, et al.
Publicado em: (2023-02-01)

EXTREME NORMOBLASTOSIS IN A THALASSAEMIA INTERMEDIA PATIENT POST-SPLENECTOMY: THE ROLE OF FLOW CYTOMETRY IN DIAGNOSIS AND MANAGEMENT
por: İdil Yürekli, et al.
Publicado em: (2024-12-01)

ALLOIMMUNIZATION IN PATIENTS WITH SICKLE CELL DISEASE AND THALASSAEMIA: EXPERIENCE OF SINGLE CENTRE FROM OMAN
por: Anil Pathare, et al.
Publicado em: (2017-02-01)

Health-related quality of life and associated factors among children with Transfusion-dependent β-thalassaemia: a cross-sectional study in Guangxi Province
por: Jingyi Qiao, et al.
Publicado em: (2024-10-01)

Economic burden of adult patients with β-thalassaemia major in mainland China
por: Xuemei Zhen, et al.
Publicado em: (2023-08-01)

Genetic investigation of haemoglobinopathies in a large cohort of asymptomatic individuals reveals a higher carrier rate for β-thalassaemia in Sichuan Province (Southwestern China)
por: Xia Yu, et al.
Publicado em: (2021-03-01)

Estimation of Microalbuminuria in Children with Beta Thalassaemia Major: A Cross-sectional Study
por: YB Arun, et al.
Publicado em: (2024-03-01)

A Rare Case of Pulmonary Neuroendocrine Carcinoma in Transfusion-dependent Thalassemia Patient: Clinical Presentation, Management, and Implications
por: Lia Sasmithae, et al.
Publicado em: (2024-07-01)

The impact of chelation compliance in health outcome and health related quality of life in thalassaemia patients: a systematic review
por: Wan Jin Lee, et al.
Publicado em: (2024-02-01)

Cognitive impairment and hippocampal neuronal damage in β-thalassaemia mice
por: Nuttanan Pholngam, et al.
Publicado em: (2024-05-01)

Tactics as Empirical and Conceptual objects: Patient Activism and the Politics of Thalassaemia in Cyprus
por: Theodoros Kyriakides
Publicado em: (2016-06-01)

Blood Groups and Susceptibility to Hepatitis C Virus Infection Among β- Thalassaemia Patients
por: Najdat Shukur Mahmood
Publicado em: (2018-06-01)

Blood Groups and Susceptibility to Hepatitis C Virus Infection Among β- Thalassaemia Patients
por: Najdat Shukur Mahmood
Publicado em: (2018-06-01)

Redesigning New Policy Options for Thalassemia Prevention in Sri Lanka
por: Nadeeja Amarasinghe, et al.
Publicado em: (2022-10-01)

Juggling between the Cost and Value of New Therapies: Does Science Still Serve Patient Needs?
por: Androulla Eleftheriou, et al.
Publicado em: (2023-01-01)

Iron induces blood-brain barrier alteration contributing to cognitive impairment in β-thalassaemia mice
por: Parinda Jamrus, et al.
Publicado em: (2025-01-01)

Post-mortem study of the association between cardiac iron and fibrosis in transfusion dependent anaemia
por: Paul Kirk, et al.
Publicado em: (2017-03-01)

The Vital Role Played by Deferiprone in the Transition of Thalassaemia from a Fatal to a Chronic Disease and Challenges in Its Repurposing for Use in Non-Iron-Loaded Diseases
por: George J. Kontoghiorghes
Publicado em: (2023-07-01)

Prognostic significance of right ventricular diastolic function in thalassaemia major
por: GK Efthimiadis, et al.
Publicado em: (2008-01-01)

Reflections from a Psychologist Working with Sickle Cell and Thalassaemia Patients during the COVID-19 Pandemic
por: Dede-Kossi Osakonor, et al.
Publicado em: (2022-09-01)